We are live on ! Find out more
CLB icon

Core Laboratories

209 hedge funds and large institutions have $880M invested in Core Laboratories in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 58 increasing their positions, 73 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 17

53% more call options, than puts

Call options by funds: $279K | Put options by funds: $182K

9% more funds holding

Funds holding: 191209 (+18)

0.59% less ownership

Funds ownership: 108.81%108.22% (-0.59%)

7% less capital invested

Capital invested by funds: $946M → $880M (-$66.3M)

21% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 73

Holders
209
Holders Change
+18
Holders Change %
+9.42%
% of All Funds
2.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
38
Increased
58
Reduced
73
Closed
17
Calls
$279K
Puts
$182K
Net Calls
+$97K
Net Calls Change
-$2.04M
Name Holding Trade Value Shares
Change
Change in
Stake
AI
1
Ariel Investments
Illinois
$167M -$7.96M -412,686 -4%
BlackRock
2
BlackRock
New York
$137M +$2.66M +137,933 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$96.8M -$543K -28,123 -0.5%
DGI
4
Disciplined Growth Investors
Minnesota
$95.3M -$2.89M -149,940 -3%
EARNEST Partners
5
EARNEST Partners
Georgia
$63.8M -$1.39M -71,998 -2%
State Street
6
State Street
Massachusetts
$34.7M +$627K +32,474 +2%
T. Rowe Price Investment Management
7
T. Rowe Price Investment Management
Maryland
$20.1M +$906K +46,941 +4%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$18.3M +$105K +5,416 +0.5%
RA
9
Royce & Associates
New York
$16.8M -$1M -51,993 -5%
Fisher Asset Management
10
Fisher Asset Management
Washington
$16.3M -$945K -48,998 -5%
Morgan Stanley
11
Morgan Stanley
New York
$15.5M -$2.19M -113,282 -11%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$14.7M +$548K +28,393 +3%
BTW
13
Boston Trust Walden
Massachusetts
$10.7M +$318K +16,503 +3%
Northern Trust
14
Northern Trust
Illinois
$10M +$1.51M +78,173 +16%
FAM
15
Fred Alger Management
New York
$9.63M +$397K +20,596 +4%
Charles Schwab
16
Charles Schwab
California
$8.64M -$583K -30,223 -6%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$7.79M -$541K -28,026 -6%
VanEck Associates
18
VanEck Associates
New York
$7.68M +$506K +26,237 +6%
GJL
19
Gendell Jeffrey L
$7.45M -$590K -30,561 -7%
Raymond James Financial
20
Raymond James Financial
Florida
$6.76M +$7.54M +390,554 New
UBS Group
21
UBS Group
Switzerland
$6.53M +$6.75M +349,888 +1,286%
Goldman Sachs
22
Goldman Sachs
New York
$4.42M +$1.67M +86,801 +52%
Invesco
23
Invesco
Georgia
$4.37M -$1.63M -84,510 -25%
Envestnet Asset Management
24
Envestnet Asset Management
Illinois
$4.34M +$10.4K +537 +0.2%
ACM
25
Advisors Capital Management
New Jersey
$4M -$23.7K -1,229 -0.5%

CLB Hedge Fund Activity: Q4 2024 in Review

209 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2024, worth a combined $880M — down 7% from $946M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new CLB positions and 17 closed out — a net gain of 21 holders — while 58 added to existing stakes and 73 trimmed.

The largest buyer was UBS Group, adding an estimated $6.75M. The largest seller was Ariel Investments, cutting an estimated $7.96M.

  • 209 institutional investors held Core Laboratories (CLB) as of Q4 2024, up from 191 in Q3 2024.
  • Funds reported $880M of Core Laboratories stock for Q4 2024, down 7% quarter-over-quarter.
  • 38 funds opened new Core Laboratories positions in Q4 2024 and 17 closed out, a net change of +21 holders.
  • The largest Core Laboratories buyer in Q4 2024 was UBS Group, an estimated $6.75M added.
  • The largest Core Laboratories seller in Q4 2024 was Ariel Investments, an estimated $7.96M sold.

Based on aggregated 13F filings for Q4 2024.